MedTrace Logo

Gut Transit Effect on Enterohepatic Circulation

NCT03501498 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2022-09-30

No results posted yet for this study

Summary

A study to determine the influence of changing intestinal transit time of the enterohepatic recirculation of bile acids.

Conditions

  • Intestinal Transit

Interventions

DRUG

Loperamide

Alters intestinal transit time.

DRUG

Senna

Alters intestinal transit time.

Sponsors & Collaborators

  • University Hospital Plymouth NHS Trust

    lead OTHER

Principal Investigators

  • Stephen Lewis, MD · University Hospital Plymouth NHS Trust

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-10
Primary Completion
2018-05-07
Completion
2022-03-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03501498 on ClinicalTrials.gov